Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-05-13 @ 6:07 AM
Study NCT ID:
NCT01181258
Status:
COMPLETED
Last Update Posted:
2018-02-06
First Post:
2010-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
Sponsor:
Organization: